# Retatrutide beats Ozempic on weight loss, blood sugar control, study says

> **Open Intelligence Dossier** · First detected: 2026-10-29 00:40 UTC · Category: Business

## Executive Summary
2 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.

## Intelligence Brief
"Retatrutide beats Ozempic on weight loss, blood sugar control, study says" is generating significant coverage in the Business category, with 2 articles from 2 distinct sources tracked by PULSE so far.


Outlets currently covering the story include KHOU and WXLV. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.


This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.

## Multi-Source Evidence Table
| Source Outlet | Headline | Verification URL |
|---|---|---|
| BioPharma Dive | Lilly’s ‘triple-G’ drug tops Novo’s Ozempic in diabetes trial | [Source Link](https://news.google.com/rss/articles/CBMinAFBVV95cUxNN19wd1NRdjNRRTcwb1VndDlmVlNuZGNRMDBpWXV0aXd0UFFkTnZKb1A0dGJCdHZDd1VZN3hsVkFfcXFobTg2TDRyNVZPQ3paWkhRQWdFMHhyczdoaGlFRzhSdXNKU2pYbGcycEFRS08yaHlDZkEyVE5lUFp5RU41TklaTmN1NGFkWWZoNDdHU0EwNm1pbmszTERXUVQ?oc=5) |
| PR Newswire | Lilly's retatrutide delivered greater A1C reduction and more than double the weight loss of Ozempic's highest approved dose in head-to-head trial | [Source Link](https://news.google.com/rss/articles/CBMipgJBVV95cUxNV1Fpb2ZEcE9hUG5HamR0SklXalI2WUlNT3l6WnNRby1Bc2tJbnlmdFpGUlotM2Y4dy04TlhENjVtZDI1YXkzTzByRmh6TnFjWTdlVC11S1FjcVhmenR1bVR1U0dQV2tTS1V3ZlpyTlVQb0wwOG9ZallmVXhSWng2NmtHdG9KQjY0d0FWc1JrSlM1M3VLZ0xvX2pMajlMRklaTmpYLWp2V0lwdGd4ZGZVamItOVhscDc1SUljcHdzVURvU3JBb2pDSmVUMTR2LVo1S1JPQURtc3FtWThKYTBYUE9XSGV0ZFgzdHJ3R29TbFE0LWRFcDhwS2xhN2tQMjB3REFZZzVEcmhaYTVzY0xHOG13MlFUX1A0bmZvR1RqdzVvX0laMVE?oc=5) |
| KHOU | Eli Lilly says retatrutide shows more weight loss compared to Ozempic | [Source Link](https://news.google.com/rss/articles/CBMiyAFBVV95cUxPalk1QmJIYS1JUHVpVzBsRlRVeVFZNUFobXpuQXFPWFlkOTBndk1GOERDN3ZsNW1FY29aRDRQRTE2bXg2dUMzOTIya2FrdzlTYlpRVGdZRDExN1FnUWRUMDlTSUFNODhlT1YzTnFqdUFweTBmT2xvRnR5NDJZcDhveldob1BFUGJVVGE5UnJqNkpab2FsTHpWbVRsZjdWcndZWHlfWWxCZzcwVDk4OGVjOUthT0xYQm5OY09sMUl0bUJGaE9PdUctVw?oc=5) |
| WXLV | Experimental Lilly drug tops Ozempic in weight loss study | [Source Link](https://news.google.com/rss/articles/CBMimAFBVV95cUxQUWI0eDdvYUZCazF1UThyY21ZdGVocTJtRU1QUXFHSERXQ2VxY05rNlo3VHRtaHM5bjAtc2U4U1Zlb2xlbE85M3NTRDQxaVNjZkloVEthQnhCdWstVnNPdjJFcDY5aXoxNjdFT09vanE2R2NsOEk4bW1LTHJnZGQxNm9WUkx3cWhmV1ljcVdkaGhKbkczendfWg?oc=5) |

---
*Canonical Source: https://pulse.byoviral.com/trend/2026-10-29/retatrutide-beats-ozempic-on-weight-loss-blood-sugar-control-study-says*